Artiva Biotherapeutics (ARTV) EPS (Weighted Average and Diluted): 2023-2024
Historic EPS (Weighted Average and Diluted) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $1.35.
- Artiva Biotherapeutics' EPS (Weighted Average and Diluted) rose 109.07% to $1.35 in Q4 2024 from the same period last year, while for Dec 2024 it was -$38.81, marking a year-over-year change of. This contributed to the annual value of -$5.81 for FY2024, which is 83.76% up from last year.
- Per Artiva Biotherapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $1.35 for Q4 2024, which was up 246.74% from -$0.92 recorded in Q3 2024.
- Artiva Biotherapeutics' 5-year EPS (Weighted Average and Diluted) high stood at $1.62 for Q3 2023, and its period low was -$22 during Q2 2024.
- In the last 2 years, Artiva Biotherapeutics' EPS (Weighted Average and Diluted) had a median value of -$14.89 in 2023 and averaged -$10.44.
- Within the past 5 years, the most significant YoY rise in Artiva Biotherapeutics' EPS (Weighted Average and Diluted) was 109.07% (2024), while the steepest drop was 156.79% (2024).
- Quarterly analysis of 2 years shows Artiva Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$14.89 in 2023, then surged by 109.07% to $1.35 in 2024.
- Its last three reported values are $1.35 in Q4 2024, -$0.92 for Q3 2024, and -$22 during Q2 2024.